This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Identify dividend ETFs with the cheapest expense ratios without sacrificing reliability. This guide helps distinguish leaders in low-cost access.
27,552 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
When the market shakes off retail names, patient investors can spot opportunities. Here are two retail growth stocks ...
A senior strategist at a massive $1.8 trillion fund warns that long-dated Treasuries are unlikely to shield retiremen...
The SpaceX IPO is stirring big hype, but not every spark is a signal to buy. This guide explains the worst reason spa...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
Investors are hearing bold predictions about near-term returns. This article breaks down what Wall Street says stock ...
New Fed chair Kevin Warsh signaled that reclaiming inflation credibility may require keeping rates higher for longer,...
Walmart faces a pivotal moment as macro headwinds collide with a fast-growing digital ecosystem. This report examines...
AI demand has sparked a rapid rally in memory stocks, but signs of inventory normalization and pricing pressure pose ...
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Insider sales spark questions about a stock's health. Here's a practical, data-backed guide to interpret a VP selling...
Paramount Skydance has boosted its per-share bid for Warner Bros. Discovery to $31, intensifying the competition with...